NetworkNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) F
Post# of 112
(Total Views: 205)
Posted On: 02/14/2023 3:21:48 PM
NetworkNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Forms US-Based Subsidiary with Focus to Expand Innovation Platforms
Aditxt (NASDAQ: ADTX), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced the formation of a U.S.-based wholly owned subsidiary, Pearsanta Inc. The move intends to accelerate the expansion of Aditxt’s second program, AditxtScore(TM), through future strategic revenue and growth-oriented transactions. According to the update, Anthony Voorhies, currently the head of the AditxtScore(TM) division, will serve as president of Pearsanta. Voorhies has over 20 years of clinical diagnostics and healthtech industry experience and, under his leadership, the AditxtScore(TM) division has successfully grown from inception to commercialization and revenues in just under two years. “Pearsanta is well positioned for growth in 2023,” Voorhies said in the news release. “Pearsanta’s focus is on expanding our innovation platforms through a diversified product offering and pipeline while driving revenue growth from reimbursement and cash channels. Pearsanta will also focus on enhancing operational capabilities and efficiencies, through automation and new delivery systems to rapidly scale our business and fulfill a growing market demand for personalized and precise medicine.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Aditxt (NASDAQ: ADTX), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced the formation of a U.S.-based wholly owned subsidiary, Pearsanta Inc. The move intends to accelerate the expansion of Aditxt’s second program, AditxtScore(TM), through future strategic revenue and growth-oriented transactions. According to the update, Anthony Voorhies, currently the head of the AditxtScore(TM) division, will serve as president of Pearsanta. Voorhies has over 20 years of clinical diagnostics and healthtech industry experience and, under his leadership, the AditxtScore(TM) division has successfully grown from inception to commercialization and revenues in just under two years. “Pearsanta is well positioned for growth in 2023,” Voorhies said in the news release. “Pearsanta’s focus is on expanding our innovation platforms through a diversified product offering and pipeline while driving revenue growth from reimbursement and cash channels. Pearsanta will also focus on enhancing operational capabilities and efficiencies, through automation and new delivery systems to rapidly scale our business and fulfill a growing market demand for personalized and precise medicine.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)